IndraLab
Statements
L-prolylglycine inhibits NLRP3. 11 / 11
|
1
10
reach
"Some researchers have found that PG can significantly inhibit the activation of NLRP3 inflammatory corpuscles induced by Aβ, suggesting that the neuroprotective mechanism of NLRP3-caspase-1 inflammatory corpuscles regulated by PG may be a potential therapeutic target to improve the pathophysiological process of AD[15]."